Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 24674147)

1.

The molecular biology of renal cancer: another piece of the puzzle.

Stewart GD, Harrison DJ, Berney DM, Powles T.

Eur Urol. 2014 Jul;66(1):85-6. doi: 10.1016/j.eururo.2014.03.004. Epub 2014 Mar 14. No abstract available.

PMID:
24674147
2.

Re: ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma.

Laguna MP.

J Urol. 2015 Jan;193(1):71-2. doi: 10.1016/j.juro.2014.10.015. Epub 2014 Oct 16. No abstract available.

PMID:
25523651
3.

Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.

Parker AS, Leibovich BC, Eckel-Passow JE, Cheville JC.

Eur Urol. 2014 Nov;66(5):e90-1. doi: 10.1016/j.eururo.2014.05.009. Epub 2014 May 27. No abstract available.

PMID:
24877662
5.

[Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].

Herrmann E, Wülfing C, Hartmann A.

Urologe A. 2007 Sep;46(9):1175-6. German. No abstract available.

PMID:
17646959
6.

Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?

Rouvière O, Bouvier R, Négrier S, Badet L, Lyonnet D.

Nat Clin Pract Oncol. 2006 Apr;3(4):200-13. Review.

PMID:
16596144
7.

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R.

J Exp Clin Cancer Res. 2010 Jul 7;29:90. doi: 10.1186/1756-9966-29-90. Erratum in: J Exp Clin Cancer Res. 2010;29:105.

8.

[Molecular genetic aspects of solid tumors. Presentation of modern study approaches exemplified by renal cell cancer].

Strohmeyer T, Ackermann R.

Med Klin (Munich). 1993 Jan 15;88(1):28-34. Review. German. No abstract available.

PMID:
8094882
9.

New gene mutation implicated in renal cancer. Study findings could shed light on the intricate biology of kidney cancer.

[No authors listed]

Duke Med Health News. 2011 Apr;17(4):6-7. No abstract available.

PMID:
21604427
10.

Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.

Lane BR, Li J, Zhou M, Babineau D, Faber P, Novick AC, Williams BR.

J Urol. 2009 Feb;181(2):849-60. doi: 10.1016/j.juro.2008.10.069. Epub 2008 Dec 17.

11.

[Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation].

Haferkamp A, Hohenfellner M, Hautmann R, Zöller M.

Urologe A. 2007 Sep;46(9):1292-8. German. No abstract available.

PMID:
17628779
12.

DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.

Fisel P, Kruck S, Winter S, Bedke J, Hennenlotter J, Nies AT, Scharpf M, Fend F, Stenzl A, Schwab M, Schaeffeler E.

Clin Cancer Res. 2013 Sep 15;19(18):5170-81. doi: 10.1158/1078-0432.CCR-13-1180. Epub 2013 Jul 23.

13.

Renal cell carcinoma with clear cells, smooth muscle stroma, and negative for 3p deletion: a variant of renal angiomyoadenomatous tumour? A case report.

Iczkowski KA, Shanks JH, Burdge AH, Cheng L.

Histopathology. 2013 Feb;62(3):522-4. doi: 10.1111/his.12040. No abstract available.

PMID:
23339367
14.

Future prognostic factors for renal cell carcinoma: Workgroup No. 5. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Swanson DA, Rothenberg HJ, Boynton AL, Consigliere D, Halling KC, Oda H, Smith D.

Cancer. 1997 Sep 1;80(5):997-8. No abstract available.

PMID:
9307207
15.

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.

J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036. Epub 2008 Aug 15.

PMID:
18707725
16.

Prognostic factors in renal cell carcinoma.

Ljungberg B.

Urologe A. 2004 Sep;43 Suppl 3:S119-20. No abstract available.

PMID:
15179550
17.

Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.

Zhang S, Fang J, Zhang X, Qin C, Su S, Deng Y, Song Z, Zhang Y, Wang H, Yin C, Wang Z.

Tumour Biol. 2014 Sep;35(9):9095-100. doi: 10.1007/s13277-014-2184-6. Epub 2014 Jun 11.

PMID:
25027395
18.

Editorial comment.

Russo P.

Urology. 2011 Apr;77(4):847-8. doi: 10.1016/j.urology.2010.10.050. No abstract available.

PMID:
21477710
19.

CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy.

Feng G, Fang F, Liu C, Zhang F, Huang H, Pu C.

Int Urol Nephrol. 2012 Dec;44(6):1663-9. doi: 10.1007/s11255-012-0255-4. Epub 2012 Jul 25.

PMID:
22826148
20.

CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.

Weiss JM, Gregory Alvord W, Quiñones OA, Stauffer JK, Wiltrout RH.

Hum Immunol. 2014 Jul;75(7):614-20. doi: 10.1016/j.humimm.2014.04.018. Epub 2014 May 4.

PMID:
24801648
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk